BRACAnalysis CDx is now the only germline test approved by FDA as a companion diagnostic for treatment of HER2 negative high-risk early-stage breast cancer
Company launches Precise™ Tumor test, part of a comprehensive suite combining germline, tumor and companion diagnostics in one easy-to-access solution
Acquisition offers new, differentiated, and potentially best-in-class approach to address needs of a broader number of patients with immuno-inflammatory diseases
PolarityTE Announces $5.0 Million Registered Direct Offering
The Senate HELP Committee on Tuesday voted 20-2 to advance legislation, the PREVENTS Pandemic Act.
Co-Diagnostics announced that its Board of Directors has authorized a share repurchase program that would allow the Company to repurchase up to $30 million of CODX common stock.
Legislation would combat corrupt Chinese Courts from issuing “anti-suit injunctions” that prevent companies from challenging patent infringement from Chinese companies in American courts.
The 2022 Wilson Sonsini Entrepreneur and Investor Life Sciences Summit presented by BioUtah, BioHive and the PIVOT Center attracted a record setting 300+ registrants along with an impressive line-up of distinguished speakers, national and local investors and numerous Utah life sciences startups. Now in its 7th year, the Summit (our first in person since COVID-19) […]
Xenter has leased 30,000 square feet to accommodate explosive growth in the new Irvine Office Park in Draper, Utah.
myIntelX will be launching in conjunction with KidneyIntelX going live at Atrium Health, and will expand testing services across all Renalytix healthcare provider partners
IONIQ Sciences announced that it has acquired from OT Acceptance, LLC certain intellectual property formerly licensed to the Company by OT Acceptance.
Innovative Embolic Device by Fluidx Medical Used Successfully in a Variety of Complex Cancer Cases
Collaboration aims to capture patient-to-patient variability to determine the best treatment for every cancer
Halia Therapeutics New Leadership Team
BD Names William ‘Bill’ Brown to Board of Directors
Allogeneic discogenic cell therapy was well tolerated and produced clinically meaningful, statistically significant improvements in low back pain, function, and quality of life by 12 weeks following intradiscal injection; improvements were sustained at the one-year interim readout with additional data to follow at 18 and 24 months.
Merit Medical shares were up today on fourth-quarter results that topped the consensus forecast.
Americans with diabetes will have access to more affordable insulins through a transparent, cost-plus model
MDMA Urgent Request: Medical Supplies for Ukraine Needed
ARUP Laboratories has renamed its expert team of healthcare consultants as ARUP Healthcare Advisory Services.
Foldax announced the presentation of results from the first animal study of its transcatheter valve from the TRIA™ biopolymer heart valve portfolio
Over the last couple of weeks, health legislative staff for Utah Reps. Chris Stewart (R-UT) and John Curtis (R-UT) have been touring a number of the state’s life sciences companies to learn more about their innovative work and our growing BioHive. Colleen Malloy White, on behalf of Curtis, visited IONIQ Sciences, ARUP Laboratories and ATL […]
BioUtah is pleased to recognize Rare Disease Day, designated as February 28. There are approximately 7,000 rare diseases, affecting an estimated 25 million to 30 million Americans. Only five percent of these diseases have a treatment. The mantra of the National Organization for Rare Disorders (NORD) – “Alone we are rare. Together we are strong” […]
BD announced that Shana Neal has been appointed chief people officer.
Volunteers Needed for Weber County STEM events
Myriad Genetics announced financial results for its fourth quarter and year ended Dec. 31, 2021.
SINTX Technologies announced new results on the development of manufacturing technologies to produce fabrics impregnated with SINTX silicon nitride, and the antipathogenic testing of these fabrics.
Renalytix announced its intention to appoint Timothy Scannell to its board of directors as an independent non-executive director.
PolarityTE announced results from a multi-center randomized controlled trial evaluating treatment of Venous Leg Ulcers (VLU) with its investigational product SkinTE® plus standard of care (SOC) vs SOC alone (NCT03881267).
In this year’s legislative session, two bills could be problematic for life sciences companies in Utah. HB60 prohibits employers from requiring proof of vaccination from employees or patrons. While it provides an exemption for federally regulated entities like hospitals, it does not provide an exemption for life sciences employees who interact with those institutions who […]
Life Sciences Day on Capitol Hill was held on February 16 filling the Capitol rotunda with 24 companies showcasing their innovations to lawmakers and collectively, reflecting the strength of Utah’s BioHive. Lt. Governor Deidre Henderson was on hand to personally visit with company representatives and learn about the important work they’re doing to advance healthcare. […]
